OR8B2/OR8B3 Antibody

What are OR8B2 and OR8B3 receptors, and why are they important in research?

OR8B2 and OR8B3 are members of the olfactory receptor gene family that play crucial roles in detecting specific odors and triggering olfactory responses. These proteins belong to the large family of G-protein-coupled receptors (GPCRs) arising from single coding-exon genes . They share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals . Understanding the function and regulation of these receptors is essential for unraveling the complexities of human olfaction and sensory perception, potentially providing insights into odor-related disorders and contributing to the development of novel odor-based therapeutics or applications in various industries .

What is the molecular weight and structure of the OR8B2/OR8B3 proteins?

The OR8B2/OR8B3 proteins have different molecular weight bands that have been identified through immunoblotting. When using specific antibodies like the OSA Mabs, three distinct protein bands of apparent molecular weights 42,000, 59,000, and 66,000 Da have been detected . Interestingly, different patterns of bands are observed depending on the tissue samples: the 42,000 and 59,000 Da bands are found in cell bodies and initial segments of axons and dendrites, while the 42,000 and 66,000 Da bands are present in distal segments of axons and their terminals . This suggests a post-translational modification process where the 59,000 Da protein is modified to the 66,000 Da protein during axonal transport . Other sources indicate a calculated molecular weight of approximately 34,661 Da for OR8I2, a related olfactory receptor , suggesting that the molecular weight may vary among different olfactory receptor family members.

What are the key characteristics of commercially available OR8B2/OR8B3 antibodies?

Several commercial OR8B2/OR8B3 antibodies are available with varying specifications:

When selecting an antibody, researchers should consider which applications they need the antibody for, the species reactivity required, and whether validation data is available for their specific application . The data shows that most available antibodies are rabbit polyclonal antibodies targeting human OR8B2/OR8B3 proteins, with Western blotting being the most commonly validated application.

How should I determine which OR8B2/OR8B3 antibody is most suitable for my specific research application?

When selecting an OR8B2/OR8B3 antibody for your research, consider these methodological factors:

• Application compatibility: Ensure the antibody has been validated for your specific application (WB, ELISA, IF, ICC). For example, if you need to perform immunofluorescence, the Assay Genie PACO03849 antibody has been validated for this application at dilutions of 1:200-1:1000 .

• Epitope recognition: Review the immunogen information to determine which region of the protein the antibody targets. For instance, the Assay Genie antibody targets the internal region of the human OR8B2/3 protein , while the Antibodies.com product targets amino acids 199-248 .

• Validation data: Examine whether the manufacturer provides validation images or data for your application of interest. The Antibodies.com antibody, for example, includes Western blot validation data showing detection in Jurkat and HT-29 cells .

• Sample type compatibility: Verify that the antibody has been tested with your sample type (cell lines, tissue sections, etc.).

• Cross-reactivity: Determine whether the antibody recognizes both OR8B2 and OR8B3 or distinguishes between them, depending on your experimental needs.

Select the antibody with the most extensive validation for your specific application, and consider testing multiple antibodies if your research requires highly specific detection of either OR8B2 or OR8B3 individually.

What are the optimal conditions for Western blot analysis using OR8B2/OR8B3 antibodies?

For optimal Western blot results with OR8B2/OR8B3 antibodies, follow these methodological recommendations:

• Sample preparation: Extract proteins from tissues or cells of interest using a buffer containing protease inhibitors to prevent degradation. For olfactory receptors, which are membrane proteins, consider using specialized lysis buffers containing detergents like RIPA or NP-40 to effectively solubilize membrane fractions.

• Protein loading: Load 20-50 μg of total protein per lane, as these receptors may have relatively low expression levels in some tissues.

• Antibody dilution: Use the recommended dilution for Western blotting, typically 1:500-1:2000 for most OR8B2/OR8B3 antibodies . For example, the Antibodies.com A98683 product recommends a dilution of 1:500-1:1000 .

• Blocking: Block membranes with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature to reduce non-specific binding.

• Primary antibody incubation: Incubate with diluted OR8B2/OR8B3 antibody overnight at 4°C in blocking buffer for optimal binding.

• Secondary antibody: Use an appropriate anti-rabbit HRP-conjugated secondary antibody, as most OR8B2/OR8B3 antibodies are rabbit-derived .

• Expected band size: Look for bands at approximately 35-42 kDa, with possible additional bands at 59 kDa and 66 kDa depending on tissue type and post-translational modifications .

• Positive controls: Include Jurkat or HT-29 cell lysates as positive controls, as these have been validated for OR8B2/OR8B3 expression in previous studies .

This protocol should be optimized based on your specific experimental conditions and the particular antibody you're using.

How can I optimize immunofluorescence protocols for detecting OR8B2/OR8B3 in tissue sections?

To optimize immunofluorescence detection of OR8B2/OR8B3 in tissue sections, follow these methodological steps:

• Tissue fixation: Fix tissues in 4% paraformaldehyde for 24 hours, followed by paraffin embedding or cryopreservation. For olfactory epithelium, gentle fixation is crucial to preserve antigenic epitopes.

• Antigen retrieval: Perform heat-induced epitope retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) to unmask antigens that might have been cross-linked during fixation.

• Permeabilization: Treat sections with 0.2% Triton X-100 in PBS for 10 minutes to enhance antibody penetration into the tissue, as OR8B2/OR8B3 are membrane proteins.

• Blocking: Block with 10% normal serum (from the same species as the secondary antibody) and 1% BSA in PBS for 1 hour to reduce non-specific binding.

• Primary antibody: Apply the OR8B2/OR8B3 antibody at the recommended dilution (1:200-1:1000 for immunofluorescence) . Incubate overnight at 4°C in a humidified chamber.

• Secondary antibody: Use a fluorophore-conjugated anti-rabbit secondary antibody at 1:500 dilution and incubate for 1 hour at room temperature.

• Nuclear counterstain: Apply DAPI (1:1000) for 5 minutes to visualize nuclei.

• Control staining: Include negative controls (omitting primary antibody) and positive controls (tissues known to express OR8B2/OR8B3, such as olfactory epithelium).

• Signal amplification: For low-abundance targets, consider using tyramide signal amplification or other amplification methods to enhance detection sensitivity.

When examining results, note that OR8B2/OR8B3 immunoreactivity may be detected in cell bodies, dendrites, axons, and axon terminals, as observed in similar olfactory receptor studies .

How can OR8B2/OR8B3 antibodies be used to study olfactory receptor trafficking and localization?

OR8B2/OR8B3 antibodies can be powerful tools for investigating receptor trafficking and localization using these advanced methodological approaches:

• Live-cell imaging: Combine OR8B2/OR8B3 antibody-based detection with fluorescently tagged marker proteins for various cellular compartments to track receptor movement in real-time.

• Subcellular fractionation: Use differential centrifugation to separate cellular components (membrane fractions, endosomes, Golgi apparatus) followed by Western blotting with OR8B2/OR8B3 antibodies to determine the subcellular localization of these receptors.

• Immunoelectron microscopy: Apply OR8B2/OR8B3 antibodies coupled with gold particles for ultra-high-resolution localization of receptors at the subcellular level. This approach has successfully revealed membrane-associated localization of olfactory receptors and their organization in axonal fascicles in previous studies .

• Protein modification analysis: Use the OR8B2/OR8B3 antibody to immunoprecipitate the receptor proteins from different cellular compartments, followed by mass spectrometry to identify post-translational modifications that may occur during trafficking. This approach is supported by previous findings showing different molecular weight bands (59 kDa vs. 66 kDa) in cell bodies versus axon terminals, suggesting modifications during axonal transport .

• Co-immunoprecipitation: Combine OR8B2/OR8B3 antibodies with antibodies against trafficking machinery components to identify protein-protein interactions involved in receptor transport.

These methods can reveal critical insights into how OR8B2/OR8B3 receptors are transported from the endoplasmic reticulum to the cell surface and subsequently internalized, which is essential for understanding olfactory signal transduction mechanisms.

What approaches can be used to investigate the functional role of OR8B2/OR8B3 in olfactory signaling pathways?

To investigate the functional role of OR8B2/OR8B3 in olfactory signaling pathways, consider these methodological approaches:

• Calcium imaging: Transfect cells with OR8B2/OR8B3 expression constructs and use calcium-sensitive fluorescent dyes to measure intracellular calcium changes in response to various odorants, identifying potential ligands for these receptors.

• CRISPR/Cas9 gene editing: Generate OR8B2/OR8B3 knockout models to study the consequences of receptor loss on olfactory perception and signal transduction.

• Electrophysiology: Perform patch-clamp recordings on cells expressing OR8B2/OR8B3 to measure electrical responses to odorant stimulation at the single-cell level.

• G-protein coupling assays: Since olfactory receptors are G-protein coupled receptors , use BRET (Bioluminescence Resonance Energy Transfer) or FRET (Fluorescence Resonance Energy Transfer) assays to measure the interaction between OR8B2/OR8B3 and various G-protein subunits upon odorant binding.

• Phosphorylation studies: Use phospho-specific antibodies in combination with OR8B2/OR8B3 antibodies to identify signal transduction events following receptor activation.

• Structure-function analysis: Combine molecular modeling of the 7-transmembrane domain structure with site-directed mutagenesis to identify critical residues for ligand binding and signal transduction.

• Behavioral assays: In animal models, correlate changes in OR8B2/OR8B3 expression or function with behavioral responses to specific odorants.

These approaches can provide comprehensive insights into how OR8B2/OR8B3 receptors recognize specific odors and initiate the signaling cascade that ultimately leads to odor perception.

What are common challenges encountered when using OR8B2/OR8B3 antibodies and how can they be addressed?

Researchers commonly face several challenges when working with OR8B2/OR8B3 antibodies. Here are methodological solutions to address these issues:

• Low signal intensity:

  • Increase antibody concentration (but not exceeding manufacturer recommendations)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use signal amplification methods like biotin-streptavidin systems

  • Optimize antigen retrieval methods for immunohistochemistry

  • Use fresh samples and avoid repeated freeze-thaw cycles

• Multiple bands in Western blot:

  • This may be normal, as different molecular weight bands (42 kDa, 59 kDa, and 66 kDa) have been observed for olfactory receptors in different cellular compartments

  • Include a peptide competition assay to identify specific bands, similar to the control used in validation data where the antibody is blocked by the immunizing peptide

  • Use subcellular fractionation to determine if different bands correspond to different cellular locations

• Cross-reactivity with other olfactory receptors:

  • Perform parallel experiments with antibodies targeting other olfactory receptor subtypes

  • Include appropriate knockout or knockdown controls

  • Consider using more specific monoclonal antibodies if available

• Background staining in immunohistochemistry:

  • Optimize blocking conditions using 5-10% normal serum from the secondary antibody species

  • Include additional blocking steps with avidin/biotin if using biotin-based detection systems

  • Increase washing time and number of washes between steps

  • Use more dilute antibody concentrations

• Inconsistent results between experiments:

  • Standardize protocols and use the same antibody lot when possible

  • Include positive control samples in each experiment (e.g., Jurkat or HT-29 cells)

  • Maintain consistent sample processing methods

Following these troubleshooting approaches will help improve the reliability and reproducibility of experiments using OR8B2/OR8B3 antibodies.

How can I validate the specificity of OR8B2/OR8B3 antibody binding in my experimental system?

To rigorously validate the specificity of OR8B2/OR8B3 antibody binding, implement these methodological approaches:

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before application to your samples. This should abolish specific binding, as demonstrated in validation data for commercial antibodies . The disappearance of bands or staining indicates those signals were specific to the OR8B2/OR8B3 epitope.

• Genetic approaches:

  • Use CRISPR/Cas9 or siRNA to knock out/down OR8B2/OR8B3 expression in cell lines

  • Compare antibody staining between wild-type and knockout/knockdown samples

  • The specific signal should be reduced or eliminated in knockout/knockdown samples

• Multiple antibody validation:

  • Use multiple antibodies targeting different epitopes of OR8B2/OR8B3

  • Consistent patterns across different antibodies increase confidence in specificity

  • Consider antibodies from different vendors like Assay Genie, Invitrogen, and St John's Laboratory

• Recombinant expression:

  • Overexpress tagged versions of OR8B2/OR8B3 in cell lines

  • Compare antibody staining with tag-specific antibodies

  • Colocalization suggests specificity of the OR8B2/OR8B3 antibody

• Mass spectrometry validation:

  • Immunoprecipitate proteins using the OR8B2/OR8B3 antibody

  • Analyze precipitated proteins by mass spectrometry

  • Confirm presence of OR8B2/OR8B3 peptides in the precipitated material

• Tissue distribution comparison:

  • Compare antibody staining patterns with known mRNA expression patterns

  • Concordance between antibody staining and mRNA expression supports specificity

These validation approaches provide complementary evidence for antibody specificity and should be selected based on your experimental system and available resources.

How are OR8B2/OR8B3 antibodies being used in current research on olfactory disorders and neurodegenerative diseases?

OR8B2/OR8B3 antibodies are emerging as important tools in investigating the relationship between olfactory function and various disorders:

• Olfactory dysfunction biomarkers: Researchers are using OR8B2/OR8B3 antibodies to examine changes in receptor expression patterns in conditions with olfactory impairments. Since olfactory receptors play crucial roles in detecting specific odors and triggering olfactory responses , altered expression may serve as biomarkers for sensory disruption.

• Neurodegenerative disease studies: Olfactory dysfunction often precedes clinical symptoms in neurodegenerative conditions like Alzheimer's and Parkinson's diseases. OR8B2/OR8B3 antibodies are being used to investigate whether specific changes in these receptors correlate with disease progression, potentially establishing early diagnostic markers.

• Mechanistic investigations: By combining OR8B2/OR8B3 antibodies with other molecular tools, researchers are exploring the molecular mechanisms underlying olfactory dysfunction. The ability to detect these receptors in cell bodies, dendrites, axons, and axon terminals allows for comprehensive analysis of receptor distribution and trafficking abnormalities in disease states.

• Developmental studies: OR8B2/OR8B3 antibodies are being employed to study the development of the olfactory system and how disruptions in receptor expression or function during critical periods might contribute to sensory processing disorders.

• Therapeutic response monitoring: As potential therapeutics for olfactory disorders are developed, OR8B2/OR8B3 antibodies provide tools to assess treatment effects on receptor expression, localization, and function.

These research directions highlight the value of OR8B2/OR8B3 antibodies in understanding the molecular basis of olfactory dysfunction and its relationship to broader neurological health.

What are the methodological considerations for studying OR8B2/OR8B3 in non-olfactory tissues?

While OR8B2/OR8B3 are primarily associated with olfactory function, emerging evidence suggests potential roles in non-olfactory tissues. When investigating these receptors outside the olfactory system, consider these methodological approaches:

• Expression level analysis:

  • Use highly sensitive detection methods like qRT-PCR to verify mRNA expression

  • Employ nested PCR approaches for low-abundance transcripts

  • Consider RNA-seq with deep sequencing coverage to detect low-level expression

  • Use multiple OR8B2/OR8B3 antibodies with different sensitivities for protein detection

• Signal amplification techniques:

  • For immunohistochemistry/immunofluorescence, use tyramide signal amplification or similar methods

  • Consider proximity ligation assays to detect protein-protein interactions with higher sensitivity

  • Use ultra-sensitive Western blotting protocols with enhanced chemiluminescence reagents

• Cell-type specific analysis:

  • Employ laser-capture microdissection to isolate specific cell populations

  • Use single-cell RNA-seq to identify cell subpopulations expressing OR8B2/OR8B3

  • Consider fluorescence-activated cell sorting (FACS) with OR8B2/OR8B3 antibodies to isolate positive cells

• Functional assays:

  • Adapt standard GPCR signaling assays to detect potentially weaker or context-dependent signaling

  • Consider non-canonical signaling pathways that might be employed in non-olfactory tissues

  • Use CRISPR/Cas9-mediated knockout to assess functional roles in non-olfactory contexts

• Controls and validation:

  • Include olfactory tissue as positive controls in all experiments

  • Use peptide competition assays to confirm specificity

  • Include multiple negative controls (tissues known not to express olfactory receptors)

  • Validate findings with orthogonal methods (e.g., mRNA detection plus protein detection)

• Subcellular localization analysis:

  • Perform careful subcellular fractionation to determine receptor localization

  • Use co-localization studies with organelle markers to identify compartmentalization

  • Consider potential post-translational modifications that might differ from olfactory tissues

These considerations will help ensure reliable detection and characterization of OR8B2/OR8B3 in non-olfactory contexts, where expression levels may be significantly lower than in olfactory tissues.